• Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

DR VIJ is Associate Professor at Washington University School of Medicine in the Division of Medical Oncology, Section of Bone Marrow Transplantation and Leukemia. Dr Vij’s primary academic interests include the treatment of hematologic malignancies and hematopoietic stem cell transplantation. He is involved in several collaborations with other members of the Siteman Cancer Center in studying the biology of plasma cell dyscrasias. He serves on numerous committees including the Core Transplant Committee of the CALGB, Project Review Committee of the Multiple Myeloma Research Consortium and on the Guidelines Committee for the National Comprehensive Cancer Network (NCCN). He is an author on numerous publications in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and numerous book chapters. He has served as a reviewer for prestigious journals including Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Experimental Hematology, and Haematologica and for the American Society of Hematology.

Areas of Clinical Interest

Stem cell transplant, multiple myeloma, myelodysplastic syndrome, hematologic malignancy, leukemia, lymphoma


Dive into the research topics where Ravi Vij is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 12 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots.
  • Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH

    Cornell, R., Hari, P., Tang, S., Biran, N., Callander, N., Chari, A., Chhabra, S., Fiala, M. A., Gahvari, Z., Gandhi, U., Godby, K., Gupta, R., Jagannath, S., Jagosky, M., Kang, Y., Kansagra, A., Kauffman, M., Kodali, S., Kumar, S. K., Lakshman, A. & 18 others, Liedtke, M., Lonial, S., Ma, X., Malek, E., Mansour, J., McGehee, E. F., Neppalli, A., Paul, B., Richardson, P., Scott, E. C., Shacham, S., Shah, J., Siegel, D. S., Umyarova, E., Usmani, S. Z., Varnado, W., Vij, R. & Costa, L., Jan 2021, In: American journal of hematology. 96, 1, p. E5-E8

    Research output: Contribution to journalLetterpeer-review

    Open Access
  • A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

    Mikhael, J., Richter, J., Vij, R., Cole, C., Zonder, J., Kaufman, J. L., Bensinger, W., Dimopoulos, M., Lendvai, N., Hari, P., Ocio, E. M., Gasparetto, C., Kumar, S., Oprea, C., Chiron, M., Brillac, C., Charpentier, E., San-Miguel, J. & Martin, T., Dec 2020, In: Leukemia. 34, 12, p. 3298-3309 12 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    5 Scopus citations
  • A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

    Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., Singhal, S., Pawlish, K., Peters, E. S., Bock, C., Mohrbacher, A., Stram, A., Berndt, S. I., Blot, W. J., Casey, G., Stevens, V. L. & 50 others, Kittles, R., Goodman, P. J., Diver, W. R., Hennis, A., Nemesure, B., Klein, E. A., Rybicki, B. A., Stanford, J. L., Witte, J. S., Signorello, L., John, E. M., Bernstein, L., Stroup, A. M., Stephens, O. W., Zangari, M., Van Rhee, F., Olshan, A., Zheng, W., Hu, J. J., Ziegler, R., Nyante, S. J., Ingles, S. A., Press, M. F., Carpten, J. D., Chanock, S. J., Mehta, J., Colditz, G. A., Wolf, J., Martin, T. G., Tomasson, M., Fiala, M. A., Terebelo, H., Janakiraman, N., Kolonel, L., Anderson, K. C., Le Marchand, L., Auclair, D., Chiu, B. C. H., Ziv, E., Stram, D., Vij, R., Bernal-Mizrachi, L., Morgan, G. J., Zonder, J. A., Huff, C. A., Lonial, S., Orlowski, R. Z., Conti, D. V., Haiman, C. A. & Cozen, W., Jan 14 2020, In: Blood Advances. 4, 1, p. 181-190 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes

    Nazha, A., Hu, Z. H., Wang, T., Lindsley, R. C., Abdel-Azim, H., Aljurf, M., Bacher, U., Bashey, A., Cahn, J. Y., Cerny, J., Copelan, E., DeFilipp, Z., Diaz, M. A., Farhadfar, N., Gadalla, S. M., Gale, R. P., George, B., Gergis, U., Grunwald, M. R., Hamilton, B. & 34 others, Hashmi, S., Hildebrandt, G. C., Inamoto, Y., Kalaycio, M., Kamble, R. T., Kharfan-Dabaja, M. A., Lazarus, H. M., Liesveld, J. L., Litzow, M. R., Majhail, N. S., Murthy, H. S., Nathan, S., Nishihori, T., Pawarode, A., Rizzieri, D., Sabloff, M., Savani, B. N., Schachter, L., Schouten, H. C., Seo, S., Shah, N. N., Solh, M., Valcárcel, D., Vij, R., Warlick, E., Wirk, B., Wood, W. A., Yared, J. A., Alyea, E., Popat, U., Sobecks, R. M., Scott, B. L., Nakamura, R. & Saber, W., Nov 2020, In: Biology of Blood and Marrow Transplantation. 26, 11, p. 2139-2146 8 p.

    Research output: Contribution to journalArticlepeer-review

  • Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

    Jasielec, J. K., Kubicki, T., Raje, N., Vij, R., Reece, D., Berdeja, J., Derman, B. A., Rosenbaum, C. A., Richardson, P., Gurbuxani, S., Major, S., Wolfe, B., Stefka, A. T., Stephens, L., Tinari, K. M., Hycner, T., Rojek, A. E., Dytfeld, D., Griffith, K. A., Zimmerman, T. M. & 1 others, Jakubowiak, A. J., Nov 26 2020, In: Blood. 136, 22, p. 2513-2523 11 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
If you made any changes in Pure these will be visible here soon.